申请人:TANABE SEIYAKU CO., LTD.
公开号:EP0430459A1
公开(公告)日:1991-06-05
A tetrahydronaphthalene derivative of the formula:
wherein R¹ is a substituted or unsubstituted phenyl group, naphthyl group, a sulfur- or nitrogen-containing heterocyclic group, a lower alkyl group or cycloalkyl group, and R² is hydroxymethyl group, carboxyl group, a lower alkoxycarbonyl group or a group of the formula:
wherein R³ is hydrogen atom or a lower alkyl group, R⁴ is a lower alkoxycarbonyl-phenyl group, carboxy-phenyl group, a lower alkyl group, a lower alkoxycarbonyl-lower alkyl group or carboxy-lower alkyl group, and m and n are different and are 1 or 2, or a pharmaceutically acceptable salt thereof, which are useful as a platelet aggregation-inhibiting agent and as an agent for the treatment, amelioration and/or prophylaxis of a variety of thrombosis or embolism, coronary and cerebral vascular smooth muscle vellication, asthma, and the like, processes for the preparation thereof, and pharmaceutical composition containing said compound as an active ingredient.
式中的四氢萘衍生物:
其中 R¹ 是取代或未取代的苯基、萘基、含硫或含氮杂环基、低级烷基或环烷基,R² 是羟甲基、羧基、低级烷氧羰基或式中的基团:
其中 R³ 是氢原子或低级烷基,R⁴ 是低级烷氧羰基-苯基、羧基-苯基、低级烷基、低级烷氧羰基-低级烷基或羧基-低级烷基,且 m 和 n 不同且为 1 或 2,或其药学上可接受的盐、可用作血小板聚集抑制剂和治疗、改善和/或预防各种血栓形成或栓塞、冠状动脉和脑血管平滑肌肿胀、哮喘等疾病的药物、其制备工艺以及含有上述化合物作为活性成分的药物组合物。